WuXi PharmaTech (Cayman) Inc. saw a big move last session, as the company’s shares fell by nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for WX, as the stock is now down about 14% in the past one-month time frame.
The pharmaceutical and biotechnology R&D outsourcing company has seen a flat track record when it comes to current year estimate revisions over the past few weeks and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
WX currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.
Investors interested in the Medical-Drugs industry may consider better-ranked stock like Portola Pharmaceuticals, Inc. (PTLA - Free Report) , which carries a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>